How does methyldopa impact platelet aggregation and clotting factors and what are the potential risks for patients with clotting disorders?
Lakshya KumarExplorer
What are the impacts of methyldopa on platelet aggregation and clotting factors?
Share
Methyldopa reduces platelet aggregation and can alter clotting factor activity, potentially increasing bleeding risks in patients with clotting disorders.